Jennifer Edelmann

3.5k total citations
22 papers, 1.0k citations indexed

About

Jennifer Edelmann is a scholar working on Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jennifer Edelmann has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jennifer Edelmann's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and Advanced Breast Cancer Therapies (5 papers). Jennifer Edelmann is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and Advanced Breast Cancer Therapies (5 papers). Jennifer Edelmann collaborates with scholars based in Germany, United Kingdom and Austria. Jennifer Edelmann's co-authors include Stephan Stilgenbauer, Andreas Bühler, Hartmut Döhner, Thorsten Zenz, Dirk Winkler, Sonja Häbe, Michael Hallek, Raymonde Busch, Barbara Eichhorst and Manfred Hensel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Cancer.

In The Last Decade

Jennifer Edelmann

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Edelmann Germany 12 812 564 352 257 237 22 1.0k
Jitka Malčíková Czechia 17 794 1.0× 548 1.0× 338 1.0× 280 1.1× 335 1.4× 43 1.1k
Eugen Tausch Germany 18 686 0.8× 536 1.0× 309 0.9× 308 1.2× 188 0.8× 72 1.0k
Sonja Häbe Germany 4 774 1.0× 545 1.0× 297 0.8× 173 0.7× 238 1.0× 5 893
Ludger Sellmann Germany 19 683 0.8× 426 0.8× 526 1.5× 344 1.3× 269 1.1× 34 1.1k
Yvona Brychtová Czechia 19 704 0.9× 450 0.8× 385 1.1× 422 1.6× 294 1.2× 71 1.2k
Marwan Kwok United Kingdom 10 522 0.6× 422 0.7× 277 0.8× 320 1.2× 288 1.2× 15 881
Johannes Bloehdorn Germany 14 581 0.7× 437 0.8× 320 0.9× 320 1.2× 137 0.6× 34 891
Larry Mansouri Sweden 19 591 0.7× 397 0.7× 307 0.9× 394 1.5× 170 0.7× 37 944
Andrew Greaves United States 11 1.1k 1.3× 780 1.4× 623 1.8× 241 0.9× 129 0.5× 23 1.2k
Timothy J. Murphy United States 9 778 1.0× 799 1.4× 399 1.1× 192 0.7× 310 1.3× 19 1.2k

Countries citing papers authored by Jennifer Edelmann

Since Specialization
Citations

This map shows the geographic impact of Jennifer Edelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Edelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Edelmann more than expected).

Fields of papers citing papers by Jennifer Edelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Edelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Edelmann. The network helps show where Jennifer Edelmann may publish in the future.

Co-authorship network of co-authors of Jennifer Edelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Edelmann. A scholar is included among the top collaborators of Jennifer Edelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Edelmann. Jennifer Edelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edelmann, Jennifer, Jitka Malčíková, & John C. Riches. (2023). Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?. Frontiers in Oncology. 13. 1106579–1106579. 1 indexed citations
2.
Edelmann, Jennifer. (2022). NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia. Frontiers in Oncology. 12. 1019730–1019730. 4 indexed citations
3.
Edelmann, Jennifer, Karlheinz Holzmann, D. Britton, et al.. (2021). Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways. iScience. 24(2). 102089–102089. 16 indexed citations
4.
Edelmann, Jennifer, Karlheinz Holzmann, David J. Britton, et al.. (2019). Rituximab and Obinutuzumab Induce Direct B-Cell Death Via B-Cell Receptor (BCR) Signaling, but Rituximab Elicits Stronger BCR-Derived Pro-Survival Signals Diminishing Apoptosis. Blood. 134(Supplement_1). 1579–1579. 2 indexed citations
5.
Klymenko, Tetyana, Johannes Bloehdorn, Jasmin Bahlo, et al.. (2017). Lamin B1 regulates somatic mutations and progression of B-cell malignancies. Leukemia. 32(2). 364–375. 22 indexed citations
6.
Jebaraj, Billy Michael Chelliah, Christof Schneider, Jennifer Edelmann, et al.. (2017). Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome. Leukemia & lymphoma. 59(7). 1614–1623. 13 indexed citations
7.
Edelmann, Jennifer & John G. Gribben. (2017). Managing Patients With TP53-Deficient Chronic Lymphocytic Leukemia. Journal of Oncology Practice. 13(6). 371–377. 12 indexed citations
8.
Edelmann, Jennifer & John G. Gribben. (2016). Obinutuzumab For The Treatment Of Indolent Lymphoma. Future Oncology. 12(15). 1769–1781. 7 indexed citations
9.
10.
Edelmann, Jennifer, Stefan Ibach, Karlheinz Holzmann, et al.. (2014). High Resolution Genomic Profiling of Primary “Ultra High Risk” and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial. Blood. 124(21). 3288–3288.
11.
Jebaraj, Billy Michael Chelliah, Raymonde Busch, Thorsten Zenz, et al.. (2013). Telomere Length and Treatment Outcome In Chronic Lymphocytic Leukemia: Results From The CLL8 Trial. Blood. 122(21). 671–671. 1 indexed citations
12.
Edelmann, Jennifer, et al.. (2010). Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL. International Journal of Cancer. 128(7). 1747–1750. 16 indexed citations
13.
Zenz, Thorsten, Barbara Eichhorst, Raymonde Busch, et al.. (2010). TP53 Mutation and Survival in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 28(29). 4473–4479. 413 indexed citations
14.
Edelmann, Jennifer, Karlheinz Holzmann, Lars Bullinger, et al.. (2010). High-Resolution SNP-Array Profiling of Chronic Lymphocytic Leukemia. Blood. 116(21). 50–50. 2 indexed citations
15.
Zenz, Thorsten, Julia Mohr, Jennifer Edelmann, et al.. (2009). Treatment resistance in chronic lymphocytic leukemia–the role of the p53 pathway. Leukemia & lymphoma. 50(3). 510–513. 26 indexed citations
16.
Edelmann, Jennifer, Ludger Klein‐Hitpaß, Alexander Carpinteiro, et al.. (2008). Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells. Leukemia Research. 32(10). 1565–1572. 55 indexed citations
17.
Zenz, Thorsten, Alexander Kröber, Katrin Scherer, et al.. (2008). Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood. 112(8). 3322–3329. 269 indexed citations
18.
Hüttmann, Andreas, Ludger Klein‐Hitpaß, Jürgen Thomale, et al.. (2006). Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia. 20(10). 1774–1782. 69 indexed citations
19.
Aust, Gabriela, Elke Brylla, N. G. Morgenthaler, et al.. (2006). Graves' disease (GD) and Hashimoto's thyroiditis (HT) in monozygotic twins: case study as well as transcriptomic and immunohistological analysis of thyroid tissues. Experimental and Clinical Endocrinology & Diabetes. 114(S 1). 5 indexed citations
20.
Aust, Gabriela, Kai Krohn, N. G. Morgenthaler, et al.. (2005). Graves’ disease and Hashimoto’s thyroiditis in monozygotic twins: case study as well as transcriptomic and immunohistological analysis of thyroid tissues. European Journal of Endocrinology. 154(1). 13–20. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jitka Malčíková Breakdown of academic impact, for papers by Eugen Tausch Breakdown of academic impact, for papers by Sonja Häbe Breakdown of academic impact, for papers by Ludger Sellmann Breakdown of academic impact, for papers by Yvona Brychtová Breakdown of academic impact, for papers by Marwan Kwok Breakdown of academic impact, for papers by Johannes Bloehdorn Breakdown of academic impact, for papers by Larry Mansouri Breakdown of academic impact, for papers by Andrew Greaves Breakdown of academic impact, for papers by Timothy J. Murphy
Rankless by CCL
2026